A randomized controlled study of trimethoprim‐sulfamethoxazole <i>versus</i> norfloxacin for the prevention of infection in cirrhotic patients

Abstract

This study failed to demonstrate a difference between N and T-S groups in their effects on preventing infection in patients with liver cirrhosis. T-S can be considered an alternative first-line therapy for infection prophylaxis.